Breathe Well Live Well
Lung Disease News |
Gallopamil Proves to Be an Effective Therapy in Severe Asthma
Lung Disease News Asthma is a common chronic inflammatory lung disease characterized by airflow obstruction that causes wheezing (whistling sound when the person breathes), shortness of breath, chest tightness, and coughing. This respiratory disorder is thought to be … |
View full post on asthma – Google News
|
Genentech to Present at 2015 COPD & Asthma Conference on Biomarker …
Lung Disease News Biotechnology company Genentech has been invited to present at the 11th Asthma & COPD conference, an annual event that will gather some of the most internationally prominent scientists, clinicians and industry leaders to discuss the latest findings on … |
View full post on asthma – Google News
Lung Disease News |
Handheld Device Can Diagnose Asthma With One Drop of Blood
Lung Disease News In asthmatic patients, Neutrophils migrate to the lungs when other cells of the immune system within the lung tissue become stimulated and begin to release type of proteins called chemokines. The new handheld device is a microfluidic device that … |
View full post on asthma – Google News
Medical Jane |
Cannabis Smoke May Benefit Asthma and Lung Functions
Medical Jane Regardless, many studies have shown that cannabis use may benefit asthma patients and enhance general lung function by acting as a bronchodilator, rather than a bronchoconstrictor. In fact, a new study in the Journal of Pharmacology and Experimental … |
View full post on asthma – Google News
|
Asthma Severity and Lung Function Effectively Assessed with Dynamic Oxygen …
Lung Disease News sem nome A new study assessed the feasibility and reproducibility of dynamic oxygen-enhanced magnetic resonance imaging (OE-MRI) as a non-invasive, non-ionizing imaging technique with the capability to assess regional lung function in asthma. |
View full post on asthma – Google News
 |
Clinical assessment of speech correlates well with lung function during induced bronchoconstriction.
NPJ Prim Care Respir Med. 2015;25:15006
Authors: Tayler N, Grainge C, Gove K, Howarth P, Holloway J
Abstract
Clinical assessment of asthma often includes a crude assessment of speech, for example whether the patient can speak in full sentences. To date, this statement, despite appearing in national asthma guidelines, has not been related to lung function testing in asthma exacerbation. Seven asthmatics underwent a bronchial challenge and were then recorded reading a standardised text for 1?min. The recordings were played to 88 healthcare professionals who were asked to estimate FEV1% predicted. Health care professionals’ estimations showed moderate correlation to FEV1% predicted (rho=0.61 P<0.01). There were no significant differences between professionals grouped by seniority or speciality. Speech can intuitively be estimated by health care professionals with moderate accuracy. This gives an evidence basis for the assessment in speech in acute asthma and may provide a new avenue for monitoring.
PMID: 25719976 [PubMed – in process]
View full post on pubmed: asthma
Lung Disease News |
Possible Link Between Suicide Risk and Asthma – Atopy Focus of Recent Study
Lung Disease News Asthma and atopy, the genetic tendency to develop allergic diseases, have been suggested to be associated with a higher risk of suicide ideation and depression. Bristol researchers have studied this possible link between pre-defined asthma and atopy … |
View full post on asthma – Google News
|
Boehringer Presents New Phase III Data for Asthma Therapy Tiotropium
Lung Disease News Boehringer Ingelheim Pharmaceutical company Boehringer Ingelheim recently presented encouraging data regarding its investigational drug tiotropium delivered through the company's Respimat inhaler, for the treatment of asthma. The data was presented … Tiotropium improves lung function in asthma, regardless of allergic status |
View full post on asthma – Google News
|
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function …
PR Newswire (press release) HOUSTON, Feb. 21, 2015 /PRNewswire/ — Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat® inhaler from five Phase III trials from the UniTinA-asthma® program at the 2015 American Academy of Allergy, … |
View full post on asthma – Google News
Lung Disease News |
Study Highlights Need For Greater Treatment Practice Standardization Of …
Lung Disease News shutterstock_224584318 The heterogeneity of asthma, comprising a group of related disorders that can be caused or contributed to by a diverse range of factors, makes the disease challenging to study and treat. In addressing that issue, the Cincinnati … |
View full post on asthma – Google News